In mouse models using human ovarian cancer xenografts, IL-12 secreting CAR T cells exhibit enhanced anti-tumor efficacy exemplified by increased survival, prolonged persistence of T cells, and higher systemic IL-12 and IFN-γ levels [22]. Here, IFNG is linked to neoplasm.